A.R.T. Advisors’s Larimar Therapeutics LRMR Stock Holding History

A.R.T. Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,678	Closed	-$22K	–	580
2019 Q4	$22K	Buy	+1,678	New	+$16K	﹤0.01%	1279
2019 Q3	–	Sell	-2,423	Closed	-$35K	–	1593
2019 Q2	$35K	Buy	+2,423	New	+$64.5K	﹤0.01%	1266
2019 Q1	–	Sell	-3,508	Closed	-$208K	–	1478
2018 Q4	$208K	Buy	3,508 +1,839	+110%	+$182K	0.01%	1054
2018 Q3	$234K	Buy	+1,669	New	+$203K	0.01%	1136
2018 Q2	–	Sell	-1,921	Closed	-$171K	–	1623
2018 Q1	$171K	Buy	1,921 +742	+63%	+$62.9K	0.01%	1291
2017 Q4	$65K	Buy	1,179 +155	+15%	+$6.99K	﹤0.01%	1285
2017 Q3	$43K	Sell	1,024 -2,110	-67%	-$87.7K	﹤0.01%	1265
2017 Q2	$132K	Buy	3,134 +2,239	+250%	+$115K	0.01%	1225
2017 Q1	$50K	Sell	895 -1,080	-55%	-$53.6K	﹤0.01%	1326
2016 Q4	$75K	Buy	+1,975	New	+$80.1K	﹤0.01%	1184
2016 Q3	–	Sell	-5,709	Closed	-$410K	–	932
2016 Q2	$410K	Sell	5,709 -7,751	-58%	-$613K	0.02%	865
2016 Q1	$1.08M	Sell	13,460 -667	-5%	-$52.7K	0.05%	552
2015 Q4	$1.07M	Buy	+14,127	New	+$2.27M	0.05%	529

Other funds holding LRMR

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return